Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

• Status: Completed
• Trial end date: 2016-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Influence of the vitreomacular interface on the progression of diabetic macular edema after treatment with intravitreal injection of vascular endothelial growth factor inhibitors

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundació Institut Germans Trias i Pujol
• Treatments: Ranibizumab

Criteria

Inclusion Criteria:

• diabetic macular edema treatable with antiangiogenic drugs

Exclusion Criteria:

• age under 18

• cardiovascular events during the last year

• previous vitrectomy

• previous macular edema treatment during the last 4 months